These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1278 related items for PubMed ID: 27784735
21. Plasma lipoprotein(a) levels in patients with homozygous autosomal dominant hypercholesterolemia. Sjouke B, Yahya R, Tanck MWT, Defesche JC, de Graaf J, Wiegman A, Kastelein JJP, Mulder MT, Hovingh GK, Roeters van Lennep JE. J Clin Lipidol; 2017; 11(2):507-514. PubMed ID: 28502508 [Abstract] [Full Text] [Related]
22. Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Ison HE, Clarke SL, Knowles JW. ; 1993. PubMed ID: 24404629 [Abstract] [Full Text] [Related]
23. Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia. Ohta N, Hori M, Takahashi A, Ogura M, Makino H, Tamanaha T, Fujiyama H, Miyamoto Y, Harada-Shiba M. J Clin Lipidol; 2016; 10(3):547-555.e5. PubMed ID: 27206942 [Abstract] [Full Text] [Related]
29. Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia. Alnouri F, Athar M, Al-Allaf FA, Abduljaleel Z, Taher MM, Bouazzaoui A, Al Ammari D, Karrar H, Albabtain M. Atherosclerosis; 2018 Oct 03; 277():425-433. PubMed ID: 30270081 [Abstract] [Full Text] [Related]
32. The island of Gran Canaria: A genetic isolate for familial hypercholesterolemia. Sánchez-Hernández RM, Tugores A, Nóvoa FJ, Brito-Casillas Y, Expósito-Montesdeoca AB, Garay P, Bea AM, Riaño M, Pocovi M, Civeira F, Wägner AM, Boronat M. J Clin Lipidol; 2019 Oct 03; 13(4):618-626. PubMed ID: 31153816 [Abstract] [Full Text] [Related]
37. Spectrum of mutations in homozygous familial hypercholesterolemia in India, with four novel mutations. Setia N, Saxena R, Arora A, Verma IC. Atherosclerosis; 2016 Dec 03; 255():31-36. PubMed ID: 27816806 [Abstract] [Full Text] [Related]
38. Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia. Defesche JC, Stefanutti C, Langslet G, Hopkins PN, Seiz W, Baccara-Dinet MT, Hamon SC, Banerjee P, Kastelein JJP. J Clin Lipidol; 2017 Dec 03; 11(6):1338-1346.e7. PubMed ID: 28964736 [Abstract] [Full Text] [Related]
39. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population. Radovica-Spalvina I, Latkovskis G, Silamikelis I, Fridmanis D, Elbere I, Ventins K, Ozola G, Erglis A, Klovins J. BMC Med Genet; 2015 Sep 28; 16():86. PubMed ID: 26415676 [Abstract] [Full Text] [Related]